Pamuk ON et al. |
Are Turkish Helicobacter pylori strains gaining resistance against clarithromycin? |
2000 |
Am. J. Gastroenterol. |
pmid:10926000
|
Hammerschlag MR |
Treatment of Chlamydia pneumoniae. |
2000 |
Int. J. Antimicrob. Agents |
pmid:10926449
|
Nagaya T et al. |
A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome. |
2000 |
J. Clin. Invest. |
pmid:10930442
|
Van Oijen AH et al. |
Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930892
|
Hurenkamp GJ et al. |
Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930901
|
Lai KC et al. |
Ulcer-healing drugs are required after eradication of Helicobacter pylori in patients with gastric ulcer but not duodenal ulcer haemorrhage. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930902
|
Pilotto A et al. |
Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930903
|
Kihira K et al. |
Rabeprazole, amoxycillin and low- or high-dose clarithromycin for cure of Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930904
|
Kamada T et al. |
Cetraxate, a mucosal protective agent, combined with omeprazole, amoxycillin, and clarithromycin increases the eradication rate of helicobacter pylori in smokers. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930905
|
Savarino V et al. |
OAM for cure of Helicobacter pylori infection. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10930908
|
Yamashita H et al. |
When can complete regression of low-grade gastric lymphoma of mucosa-associated lymphoid tissue be predicted after helicobacter pylori eradication? |
2000 |
Histopathology |
pmid:10931236
|
Gücüyener K et al. |
Methyl-prednisolone in neurologic complications of Mycoplasma pneumonia. |
2000 |
Indian J Pediatr |
pmid:10932970
|
Theron AJ et al. |
Investigation of the anti-inflammatory and membrane-stabilizing potential of spiramycin in vitro. |
2000 |
J. Antimicrob. Chemother. |
pmid:10933651
|
Kihara Y and Otsuki M |
Interaction of gliclazide and rifampicin. |
2000 |
Diabetes Care |
pmid:10937528
|
Morlet-Barla N et al. |
[Severe hypoglycemia and recurrence caused by disopyramide-clarithromycin interaction]. |
2000 Jul 8-15 |
Presse Med |
pmid:10938688
|
Narita N |
"Multi-effect" macrolides. |
2000 |
Intern. Med. |
pmid:10939528
|
Shivkumar K |
Images in cardiovascular medicine. Labile repolarization from "cell to bedside". |
2000 |
Circulation |
pmid:10942753
|
Kamochi H et al. |
Clarithromycin associated with torsades de pointes. |
1999 |
Jpn. Circ. J. |
pmid:10943628
|
Daudén E et al. |
Helicobacter pylori and idiopathic chronic urticaria. |
2000 |
Int. J. Dermatol. |
pmid:10944090
|
Sato K and Ebe T |
[A study on the effect of combined chemotherapy on Mycobacterium avium complex pulmonary disease]. |
2000 |
Kekkaku |
pmid:10944891
|
Katz VL et al. |
Mycobacterium chelonae sepsis associated with long-term use of an intravenous catheter for treatment of hyperemesis gravidarum. A case report. |
2000 |
J Reprod Med |
pmid:10948471
|
Mayhew BS et al. |
An in vitro model for predicting in vivo inhibition of cytochrome P450 3A4 by metabolic intermediate complex formation. |
2000 |
Drug Metab. Dispos. |
pmid:10950845
|
Boxenbaum H |
Human in vivo competitive inhibition of P450 substrates: increased plasma concentrations as a function of hepatic extraction ratio and percent inhibition. |
1999 Sep-Dec |
J Pharm Pharm Sci |
pmid:10953254
|
Gomollón F et al. |
[Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care]. |
2000 |
Med Clin (Barc) |
pmid:10953829
|
Piqué JM |
[Helicobacter pylori eradication in gastroduodenal ulcer: good, fine and not expensive]. |
2000 |
Med Clin (Barc) |
pmid:10953833
|
Fujiue Y et al. |
[Results of antimicrobial susceptibilities of strains clinically isolated at 8 institutions in Hiroshima City to major oral antimicrobial drugs, mainly new quinolone drugs. Hiroshima Levofloxacin Susceptibility Surveillance Group]. |
2000 |
Jpn J Antibiot |
pmid:10955237
|
Hatipoglu ON and Tasan Y |
A comparative efficacy and safety study of clarithromycin, roxithromycin and erythromycin stearate in mild pneumonia. |
2000 |
Yonsei Med. J. |
pmid:10957888
|
Dupas JL et al. |
[Acid suppression therapy is not required after one-week anti-Helicobacter pylori triple therapy for duodenal ulcer healing]. |
2000 Jun-Jul |
Gastroenterol. Clin. Biol. |
pmid:10962387
|
McCarty JM |
Clarithromycin in the management of community-acquired pneumonia. |
2000 |
Clin Ther |
pmid:10963284
|
Scaglione F et al. |
In vitro comparative dynamics of modified-release clarithromycin and of azithromycin. |
2000 Sep-Oct |
Chemotherapy |
pmid:10965100
|
Castellote J and Porta F |
[Combination of ranitidine and bismuth citrate plus 2 antibiotics in the eradication of Helicobacter pylori]. |
2000 |
Med Clin (Barc) |
pmid:10965489
|
Ozkan Y et al. |
Clarithromycin targeting to lung: characterization, size distribution and in vivo evaluation of the human serum albumin microspheres. |
2000 |
Farmaco |
pmid:10966162
|
Katsura Y et al. |
Anti-Helicobacter pylori agents. 4. 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid derivatives. |
2000 |
J. Med. Chem. |
pmid:10966750
|
Heep M et al. |
Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. |
2000 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10968325
|
Beyer G et al. |
Impact of moxifloxacin versus clarithromycin on normal oropharyngeal microflora. |
2000 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10968328
|
Gisbert JP et al. |
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10971230
|
Frevel M et al. |
Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens. |
2000 |
Aliment. Pharmacol. Ther. |
pmid:10971231
|
Colin AA |
Eradication of mycobacterium abscessus in a chronically infected patient with cystic fibrosis. |
2000 |
Pediatr. Pulmonol. |
pmid:10973047
|
Cattoli G et al. |
Helicobacter acinonychis eradication leading to the resolution of gastric lesions in tigers. |
2000 |
Vet. Rec. |
pmid:10975334
|
Scuderi G et al. |
Helicobacter pylori: use of a stool antigen detection test and a six-day triple therapy. |
2000 Jan-Feb |
Dig Liver Dis |
pmid:10975761
|
Buzás György M et al. |
[Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer]. |
2000 |
Orv Hetil |
pmid:10976194
|
Sohn YT et al. |
Polymorphism of clarithromycin. |
2000 |
Arch. Pharm. Res. |
pmid:10976587
|
Bosne-David S et al. |
Intrinsic resistance of Mycobacterium tuberculosis to clarithromycin is effectively reversed by subinhibitory concentrations of cell wall inhibitors. |
2000 |
J. Antimicrob. Chemother. |
pmid:10980165
|
Denis A et al. |
Beta-keto-ester chemistry and ketolides. Synthesis and antibacterial activity of 2-halogeno, 2-methyl and 2,3 enol-ether ketolides. |
2000 |
Bioorg. Med. Chem. Lett. |
pmid:10987440
|
Komine M and Tamaki K |
An open trial of oral macrolide treatment for psoriasis vulgaris. |
2000 |
J. Dermatol. |
pmid:10989574
|
Hentschel E |
[Treatment of Helicobacter pylori infections]. |
2000 |
Acta Med. Austriaca |
pmid:10989677
|
Bermudez LE et al. |
Clarithromycin-resistant mycobacterium avium is still susceptible to treatment with clarithromycin and is virulent in mice. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991834
|
Ohtani H et al. |
Comparative pharmacodynamic analysis of Q-T interval prolongation induced by the macrolides clarithromycin, roxithromycin, and azithromycin in rats. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991836
|
Rastogi N et al. |
In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991870
|
Cynamon MH et al. |
Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10991883
|